These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 24413818

  • 1. Comment on "secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot study".
    de la Taille A.
    World J Urol; 2014 Dec; 32(6):1625-6. PubMed ID: 24413818
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients.
    Khriguian J, Tsui JMG, Vaughan R, Kucharczyk MJ, Nabid A, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M, Niazi T.
    J Urol; 2021 Jun; 205(6):1648-1654. PubMed ID: 33577365
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Editorial comment. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Garnick MB.
    BJU Int; 2012 Oct; 110(8):1155. PubMed ID: 22369480
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of thrombotic thrombocytopenic purpura in metastatic prostate cancer with only endocrine therapy.
    Kanesvaran R, Phipps C, Cheng CW, Chan MM, Khoo D, Tan MH.
    Ann Acad Med Singap; 2010 Jul; 39(7):580-2. PubMed ID: 20697679
    [No Abstract] [Full Text] [Related]

  • 8. Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.
    Ragnarsson O, Johannsson G, Geterud K, Lodding P, Dahlqvist P.
    BMJ Case Rep; 2013 Aug 13; 2013():. PubMed ID: 23943809
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.
    Smith MR, Lee H, Fallon MA, Nathan DM.
    Urology; 2008 Feb 13; 71(2):318-22. PubMed ID: 18308111
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience.
    Kobayashi M, Nukui A, Suzuki K, Kurokawa S, Morita T.
    Int J Clin Oncol; 2011 Dec 13; 16(6):630-6. PubMed ID: 21512893
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Editorial comment to Japan Cancer of the Prostate Risk Assessment for combined androgen blockade including bicalutamide: clinical application and validation.
    Yoshida T.
    Int J Urol; 2013 Jul 13; 20(7):714-5. PubMed ID: 23216631
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.
    Haque R, UlcickasYood M, Xu X, Cassidy-Bushrow AE, Tsai HT, Keating NL, Van Den Eeden SK, Potosky AL.
    Br J Cancer; 2017 Oct 10; 117(8):1233-1240. PubMed ID: 29017178
    [Abstract] [Full Text] [Related]

  • 18. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
    Washino S, Hirai M, Saito K, Kobayashi Y, Arai Y, Miyagawa T.
    Low Urin Tract Symptoms; 2018 Jan 10; 10(1):57-63. PubMed ID: 27943566
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.
    Yannucci J, Manola J, Garnick MB, Bhat G, Bubley GJ.
    J Urol; 2006 Aug 10; 176(2):520-5. PubMed ID: 16813881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.